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ABSTRACT 
 
The aim of this work was to study the effect of curcumin on cell cycle in the human SK-MEL-37 melanoma cell line. 
In addition, morphological and structural analyses were also performed. Flow cytometric analysis showed a G0/G1 
arrest at 5 µM after 24 h exposure and a concentration-dependent increase in the proportion of sub-G0 
hypodiploid cells. Typical apoptotic events were also observed by the fluorescence microscopy, transmission and 
scanning electronic microscopy. Loss of mitochondrial membrane potential was not detected. Results  suggested 
that curcumin could arrest human melanoma cells at G0/G1 phase and induce a mitochondrial-independent 
apoptotic pathway.  
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INTRODUCTION 
 
Melanoma is a cancer that arises from 
melanocytes, specialized pigmented cells found 
predominantly in the skin (Gray-Schopfer et al., 
2007). This tumor is the main cause of death in 
patients with skin cancers whose incidence has 
been steadily increasing worldwide, resulting in a 
serious public health problem (Markovic et al., 
2007). Indeed, malignant melanoma cells are 
notoriously resistant to radiation and chemotherapy 
(Zheng et al., 2004). Due to the low effectiveness 
of treatments employed currently for melanoma, 
the development of new agents that are less toxic 
and do not unchain chemoresistance becomes 
primordial.  
Throughout the medical history, plant products 
have been shown to be valuable sources of novel 
anti-cancer drugs (Mans et al., 2000). The 
curcumin (diferuloylmethane) is a phenolic 
compound derived from rhizome of the turmeric 
(Curcuma longa Linn.), a perennial plant from the 
Zingiberaceae family that is widely cultivated in 
the tropical regions of Asia, most extensively in 
India, and Latin America (Araújo et al., 2001). The 
powdered dry rhizome of C. longa has been 
extensively used as dietary spice and coloring 
agent in Asian cooking and also as an herbal folk 
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medicine to treat the wounds, inflammation and 
tumors. So, curcumin has attracted considerable 
interest of the scientific community in the last 
three decades (Sharma et al., 2005). A large variety 
of pharmacological properties, including anti-
inflammatory, anti-oxidant and anti-cancer has 
been demonstrated in preclinical animal and pilot 
human studies. Moreover, curcumin can be 
considered pharmacologically safe, since is being 
consumed daily for centuries in Asian countries 
and has not been shown to cause any toxicity in 
humans (Maheswari et al., 2006; Thangapazhan et 
al., 2006). However, large-scale chemopreventive 
trials need to be performed to ensure the safety of 
curcumin to human health. 
In recent years, cell cycle arrest and apoptosis 
induction have gained wide attention as a possible 
way of eliminating the neoplasic cells. Curcumin 
has been shown to inhibit the cell growth and 
induce apoptosis in several tumor cell types, 
including murine and human melanoma cell lines 
(Chen et al, 1998; Bush et al., 2001; Aggarwal et 
al., 2003; Odot et al., 2004; Zheng et al., 2004; 
Uddin et al., 2005; Shi et al., 2006; Su et al., 
2006). However, as pointed above, melanoma may 
develop resistance to chemotherapy and up to now 
there have been no reports evaluating the effect of 
curcumin on human melanoma cell lines resistant 
to chemotherapeutic agents. In the present study, 
SK-MEL 37 human melanoma cells treated with 
curcumin were analyzed by flow cytometry, 
transmission and scanning electron microscopy, 
and fluorescence microscopy. These cells had been 
demonstrated to be resistant to doxorubicin and 
cisplatin in culture and sensitive to curcumin 
treatment openning the possibilities of therapeutic 
applications of curcumin in chemoresistant solid 
tumors as melanoma. Studies on the identification 
of possible molecular targets and more clinical 
trials in patients with melanoma could make 
possible the clinical use of curcumin as a 
chemotherapeutic safe agent. 
 
 
MATERIALS AND METHODS 
 
Reagents 
Eagle’s modified medium (MEM) was purchased 
from Sigma (St. Louis, MO, USA). Fetal bovine 
serum (FBS) was from Cultilab (Brazil).  
Curcumin (diferuloylmethane, 90% purity) was 
purchased from Fluka (USA). Propidium iodide 
(PI) was purchased from Invitrogen (USA). JC1 
(5,5, 6,6' - tetrachloro-1,1', 3,3' – 
tetraethylbenzimidazolyl carbocyanine iodide was 
purchased from Molecular Probes (USA). DAPI 
(4', 6-diamidino-2-phenylindole) was purchased 
from Sigma.  Curcumin solutions were made 200-
fold concentrated in ethanol to keep final ethanol 
concentration below 0.5% in all the experiments. 
 
Cell culture conditions 
The human melanoma cell line SK-MEL-37 
established from the metastatic melanoma nodules 
was generously donated by Dr. L. J. Old 
(Memorial Sloan-Kettering Cancer Center, N. Y., 
USA). Cells were grown in 25 cm2 tissue-culture 
flasks and maintained in modified Eagle’s medium 
(MEM) supplemented with 10% (v/v) fetal bovine 
serum (FBS), 100 U/mL penicillin and 100 µg/mL 
streptomycin (Gibco BRL) in a humidified 
atmosphere containing 5% CO2  at 37ºC. 
 
Cell cycle analysis 
Previous studies from this laboratory have shown 
relevant in vitro antiproliferative activity at 
curcumin concentrations as low as 20 µM (Rabelo 
et al, 2002). The DNA content and cell cycle 
distribution of melanoma cells treated with the 
curcumin were determined by flow cytometry. 
Exponentially growing cells were plated on culture 
dishes (100 mm diameter) at a seeding density of 3 
x 105 cells/mL. Twenty four hours after, cells were 
treated with different concentrations of curcumin 
(0, 5, 10, 15 and 20 µM) and incubated for a 
further 24 h. They were harvested and collected by 
centrifugation, washed twice in phosphate buffered 
saline (PBS, pH 7.2) and fixed with 70% cold 
absolute ethanol and kept at -20ºC until analysis. 
Just before the cell cycle determination, cells were 
centrifuged gently (50 x g for 5 min) and stained 
with 200 µL of propidium iodide (PI) solution: 
(200 µg/mL RNAse (Sigma), 20 µg/mL de PI and 
0.1% Triton X-100 (Sigma) in PBS) and incubated 
at 37ºC for 30 min. Ten thousand events were 
acquired in a flow cytometer (FACScan Becton 
Dickinson, Frankilin Lakes, New Jersey, USA) 
using a 488 nm argon laser and the data were 
analyzed using software CellQuestTM.  
 
Fluorescence microscopy  
Cells (5 x 104/well) were plated in a polystyrene 6 
well-plate (Nunc Brand Products, USA) containing 
sterile round glass coverslips and kept under 
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culture conditions. After curcumin treatments, cells 
were incubated with 20 µM of JC1, diluted in 
MEM with 10% FBS at a 1:200 ratio, during 15 
minutes at 37ºC. Then the cells were washed two 
times in PBS and 1 µM DAPI was added and 
further incubated for 30 minutes in the dark. Cells 
were washed two times with PBS and coverslips 
were mounted onto glass slides with glycerol and 
kept in the dark again. Cells were examined and 
photographed in a NIKON E6000 Eclipse 
fluorescence microscope. 
 
Transmission electron microscopy (TEM) 
For TEM analysis, cells (5 x 104) were seeded on 
culture dishes (100 mm diameter) and treated with 
5, 10, 15 and 20 µM curcumin. After collection by 
centrifugation, cells were fixed in Karnovsky´s 
solution (2.5% glutaraldehyde, 4% 
paraformaldehyde, 5 mM CaCl2,, 3% sucrose, 
buffered in  0.1 M sodium cacodylate, at pH 7.2) 
for 1 h.  After fixation, cells were rinsed in the 
same buffer, and postfixed in 1% osmium 
tetroxide, 0.8% potassium ferricyanide, and 5 mM 
CaCl2 in 0.1 M sodium cacodylate buffer. The 
material was dehydrated in a graded acetone series 
(30-100%) and embedded in Spurr resin. Ultrathin 
sections were stained with uranyl acetate and lead 
citrate and observed in a Jeol® 1011 transmission 
electron microscope at 80 kV. 
 
Scanning electron microscopy (SEM) 
Cells in suspension were attached to poly-L-lysine-
coated coverslips and immersed in fixative 
solution. Fixation was carried out at room 
temperature for 1 h in Karnovsky´s solution. 
Primary fixation was followed by rinsing in the 
same buffer and postfixation for 30 min in 
osmium-potassium ferricyanide solution. After 
fixation, the coverslips with adherent cells were 
processed through a graded ethanol series, critical 
point dried in CO2, covered with a layer of gold 
and observed in a JEOL JSM 840 scanning 
electron microscope, at an accelerating voltage of 
5.0 kV. 
 
Statistics 
Each curcumin concentration was assayed in 
triplicate and experiments were conducted four 
different sets. Graphical data points represent 
arithmetic means ± standard deviation (SD) of the 
four independent experiments. The significance 
was determined by ANOVA and Bonferroni’s post 
test. Probability values (p) of 0.05 or less were 
considered as significant. 
 
 
RESULTS 
 
Effect of curcumin on cell cycle distribution of  
SK-MEL-37 cells 
To determine whether the growth inhibition was 
attributable to cell-cycle arrest and/or apoptosis, 
flow cytometric analysis was performed. Ten 
thousands cells were recorded and results 
presented as percentage (±standard error) of cells 
in each phase (Figs. 1 and 2). The percentage of 
sub-G0 populations was: 2.36% (± 0.22), 3.53% 
(±0.49), 7.52 % (± 1.60), 11.1 % (± 1.81) and 
18.43% (± 2.12), after a 24 h treatment with 0, 5, 
10, 15 and 20 µM curcumin, respectively. There 
was no obvious increase of sub-G0 populations 
after treatment with 0.5% of pure ethanol (data not 
shown). 
Flow cytometry showed a significant increase in 
the percentage of cells in G0/G1 (p< 0.001) at 5 
µM curcumin (Fig. 2A) followed by a significant 
SG2M decrease (p<0.001) in comparison to 
control cells (Fig. 2B). This indicated that at 5 µM 
concentration, curcumin induced a G0/G1 cell 
cycle arrest. For concentrations above 5 µM, cells 
underwent apoptosis which was better 
demonstrated at a concentration of 20 µM, as the 
significant increase in sub-G0 populations 
(p<0.001) was accompanied by a significant loss of 
cells in SG2M phase (p<0.01) in relation to 
untreated cells (Fig. 1 and 2B, respectively). 
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Figure 1 - Curcumin induces DNA fragmentation in human melanoma cells. SK-MEL-37 cells (3 
X 105 cells/mL) were treated with curcumin at the indicated concentrations for 24 h. 
Asterisks represent significant difference between untreated and treated cells. Values 
are the mean ± standard error of mean (mean ± SE) of four independent experiments and 
data has been analyzed by ANOVA and Bonferroni’s post test (p< 0.001). 
 
 
 
 
A B 
 
Figures 2 - A) Curcumin induced a G0/G1
 
cell cycle arrest. B) Curcumin decreased percentage of 
cells in SG2M phase. SK-MEL-37 cells (3 X 105 cells/mL) were treated with 
curcumin at the indicated concentrations for 24 h. Asterisks represent significant  
difference between untreated and treated cells. Values are the mean (mean ± SE) of 
four independent experiments and data had been analyzed by ANOVA and 
Bonferroni’s post test (**p <0.01; *** p< 0.001). 
 
 
Morphological stimation of apoptosis 
To further characterize the apoptotic events 
morphologically, it was decided to analyze the 
results on cell cycle phases, by using fluorescence 
microscopy, transmission and scanning electron 
microscopy. Observations on the fluorescence 
microscope showed that the treatment with 
curcumin made the cells rounded (Fig. 3 B, C, D). 
Still, the treatment with 15 µM curcumin induced 
the formation of surface bebbling and 
fragmentation of the nucleus (Figs. 3 D, F). In 
contrast, untreated cells were fusiform in general 
and did not present morphological alterations (Fig. 
3A). In addition, the fragmentation of the nucleus 
in cells treated with the concentrations of 10 and 
15 µM of curcumin were observed (Figs. 3 E, F). 
*** 
*** 
*** 
*** 
*** 
 ** 
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Cells stained with the cationic dye JC1 allowed for 
the determination of mitochondrial permeability 
transition, which was measured by flow cytometry. 
Intact mitochondria tended to concentrate JC1 dye, 
which emitted red fluorescence. The ratio of red: 
green fluorescence of SK-MEL-37 cells upon 
curcumin-treated was unchanged. Curcumin did 
not induce transmitochondrial potential alterations 
(data no shown).  
 
 
 
Figure 3 - Curcumin induced morphological alterations and nucleus fragmentation in human 
melanoma cells. Cells were washed and stained with JC1 (A-D) and DAPI (E-F) and 
analysed by fluorescence microscopy. Surface bebbling (arrows) and nucleus 
fragmentation (arrow heads) could be clearly seen at 10 and 15 µM curcumin.  
 
 
Observations in the transmission electron 
microscope showed ultra structural details of 
morphological changes of the process of death 
induced by curcumin. SK-MEL-37 cells presented 
projections of membrane surface (Fig. 4 A-F). 
According to the low percentage of apoptotic 
events detected by flow cytometry (Fig. 1), 
discrete chromatin segregation at the nucleus 
periphery was observed at 5 µM curcumin for a 24 
h-treatment (Fig. 4 D). Moreover at concentrations 
above 10 µM, apoptotic characteristic events as 
heterochromatin segregation at nucleus periphery 
and intense vacuolization could also be seen even 
at 6 h incubation (Figs. 4 E-G). Apoptotic bodies 
were clearly evident after 24 h (Fig. 4 H). 
Projections of membrane were observed in 
untreated cells (Fig. 5 A). Blebs at the surface of 
the plasma membrane were clearly seen by 
scanning electron microscope at 10, 15 and 20 µM 
curcumin, corroborating the results described 
above (Fig. 5, B-D).   
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Figure 4 - Transmission electron micrographs of curcumin-treated human melanoma cells. 
Morphologic changes induced by curcumin such as segregation of the chromatin at 
the periphery of the nucleus (arrows), formation of vacuoles (hatched arrows) and 
apoptotic bodies (asterisk). Cells have been treated with (0, 5 µM, 10 µM, 15 µM) of 
curcumin for 6 hours (A, C, E) or 24 hours (B, D, F, G), respectively. Apoptotic 
bodies (asterisk) were observed after 24 hours treatment with 15 µM curcumin (Fig. 
4 H). Abbreviations: (n) nucleus, (cr) chromatin, (mt) mitochondria, (pm) plasma 
membrane. 
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Figure 5 - Scanning electron micrographs of curcumin-treated human melanoma cells Membrane 
blebs (arrows) could be clearly seen in melanoma cells treated with 10 µM, 15 µM and 
20 µM of curcumin for 24 hours (B, C, D), respectively. (A) Untreated cells. Scale 
bars: (A-C) bar= 2 mm; (D) bar= 3mm. 
 
 
DISCUSSION 
 
Plants used as food and in the folk and traditional 
medicine have been accepted currently as one of 
the main source of drug discovery and 
development. Indeed, the therapeutical potential of 
the curcumin as antitumor agent has been wide 
related in literature (Sharma et al., 2005; 
Maheswari et al., 2006; Thangapazhan et al., 
2006). Studies have suggested that phenolic, 
methoxi and ketone groups in its chemical 
structure are very important for their biological 
activities (Joe et al., 2004). Moreover, diverse 
studies have demonstrated the inhibitory effect of 
curcumin in tumorigenesis through the induction 
of apoptosis in several tumor cell lines indicating a 
therapeutic potential for cancer treatment (Chen et 
al., 1998; Bush et al., 2001; Aggarwal et al., 2003; 
Odot  et al., 2004; Zheng et al., 2004; Uddin  et al., 
2005; Shi et al., 2006; Su et al, 2006).  
Studies on the growth of SK-MEL- 37 cells had 
demonstrated cytotoxic effects of curcumin in a 
concentration range of 5 to 20 µM (Rabelo et al, 
2002). In the present study, flow cytometry 
showed that 5 µM curcumin induced a low 
percentage of apoptotic cells, although a 
significant increase in relation to control was 
observed in the cells treated with 10, 15 and 20 
µM. These results were also confirmed by 
fluorescence microscopy, TEM and SEM. 
It was shown that curcumin changed the profile of 
the cell cycle with an increase in G0/G1 population 
associated with a decrease in the SG2M cell 
population. Curiously, this effect was only 
observed at the low dose (5 µM). By stalling the 
cells in G0/G1, additional time may be gained to 
repair any cellular damage. At high doses, 
irreparable damage induced apoptosis.  
Up to now, G0/G1 cell cycle arrest has been 
reported mainly in normal curcumin-treated cells. 
Chen and Huang (1998) have demonstrated that 
curcumin treatment at 10-6-10-5M induced G0/G1 
arrest in rat aortic smooth muscle cells. Human 
umbilical vein endothelial cells (Singh, et al., 
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1996) and normal mammary epithelial cells 
(Choudhuri et al., 2005) are also arrested in G0/G1 
phase.  
Cancer cells, however, failed to be arrested in 
G0/G1 by curcumin. Curcumin induced G2/M cell 
cycle arrest has been described as leading to 
apoptosis. So, a variety of human carcinoma cells 
including breast (Simon et al. 1998), ovarian (Weir 
et al., 2007) and colon (Hanif et al., 1997; Chen et 
al., 1999) are all blocked in G2/M phase. Cultured 
human melanoma cells are also blocked in G2/M. 
It has been postulated that if cells have an 
overexpression of cyclin D1, curcumin fail to 
arrest these cancer cells and it allow them to pass 
into G2 phase and undergo apoptosis (Zheng  et 
al., 2004; Choudhuri  et al., 2005).  
In the present study, it was found that 5 µM 
curcumin could block the cells at G0/G1 phase and 
at higher concentrations curcumin could induce the 
apoptotic events in SK-MEL-37 melanoma cells. 
As mentioned above, numerous in vitro studies 
have demonstrated that curcumin exert apoptotic 
events in a variety of cancer cell lines, including 
melanoma. However, this has been the first time to 
detect a G0/G1 cell cycle arrest in human 
melanoma cells. This result suggested that the 
growth inhibitory effect of curcumin might be 
initiated by arresting the cells at G0/G1 phase 
before undergoing apoptosis.  
Curcumin also induced morphological alterations 
such as blebbing of plasma membrane, formation 
of apoptotic bodies, chromatin condensation and 
segregation at nucleus periphery, in cells treated 
with 10-20 µM. An intense accumulation of 
cytoplasmic vacuoles in cells treated with 
curcumin concentrations higher than 10 µM was 
also observed. This was described by some authors 
as autophagic vacuolization and these studies have 
indicated that both autophagy and apoptosis were 
part of the programmed cellular death and both 
could be linked (Cho and Choi, 2002, Edinger and 
Thompson, 2004, Boya et al., 2005; Polo et al., 
2005).  
Present results did not demonstrate any alteration 
of the mitochondrial transmembrane potential at all 
tested concentrations, suggesting that the process 
of apoptosis, induced by curcumin, was not 
mediated by the mitochondria in SK-MEL-37 
cells. These results agreed with the observations of 
Bush et al. (2001), showing a mitochondrial–
independent pathway in eight human melanoma 
cell lines. However, these results might be cell-
specific, since curcumin induced the apoptosis via 
mitochondria in many other types of cultured 
cancer cells (Anto et al., 2002; Woo et al., 2003; 
Hussain et al., 2006, Shankar et al., 2007). 
The success of chemotherapeutic agents would be 
attributed to its potentialities in inducing the 
apoptosis in malignant cell populations (Syng-Ai 
et al., 2004). Considering that some chemoresistant 
melanoma cells might acquire sensitivity to 
chemotherapeutic agents by pre-treating with 
purine analogs (Zaffaroni et al., 1996), present 
results suggested a possible role of curcumin as a 
modulator of classical chemotherapeutical 
compounds as cisplatin derivatives or doxorubicin 
to treat the melanoma. Clinical treatment with low 
curcumin concentrations might arrest the cells at 
G0/G1, enhancing the efficacy of the 
chemotherapeutic agent. 
Plants continue to be important for the 
development of new anti-cancer drugs. 
Considering that curcumin is a natural constituent 
of diet and demonstrate safe pharmacology, its 
therapeutic applications could become a promising 
tool. Therefore, it is important to promote the 
development of therapies that involve curcumin in 
the treatment of cancer, including melanoma.  
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RESUMO 
 
O melanoma é um tipo agressivo de câncer cujo 
tratamento culmina com o estabelecimento de 
resistência aos quimioterápicos empregados. 
Portanto, é importante o desenvolvimento de novos 
agentes farmacológicos que sejam menos tóxicos e 
que não provoquem quimiorresistência. As 
inúmeras propriedades terapêuticas da curcumina 
vêm sendo confirmadas através de estudos sobre o 
seu mecanismo de ação em células cultivadas. No 
presente estudo, empregamos células de melanoma 
humano da linhagem SK-MEL-37, que 
desenvolveram resistência in vitro à doxorubicina e 
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cisplatina, drogas normalmente utilizadas na 
clínica.  Investigamos o efeito da curcumina sobre 
o ciclo celular através de citometria de fluxo. Além 
disso, análises morfológicas e estruturais também 
foram realizadas. Os resultados demonstraram que 
o tratamento com uma concentração de 5 M  de 
curcumina provocou uma parada na subfase 
G0/G1. Além disso, observou-se um aumento 
dose-dependente na proporção de células 
hipodiplóides em sub-G0. Eventos apoptóticos 
típicos foram observados por microscopia de 
fluorescência, microscopia eletrônica de 
transmissão e microscopia eletrônica de varredura.  
Não foi detectada alteração no potencial de 
membrana mitocondrial. Os resultados indicam 
que futuros estudos poderão tornar possível a 
utilização da curcumina como um modulador para 
agentes quimioterápicos empregados na clínica no 
tratamento do melanoma. 
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